Literature DB >> 8628556

Limbal transplantation.

D T Tan1, L A Ficker, R J Buckley.   

Abstract

BACKGROUND: Limbal transplantation is a surgical technique of ocular surface epithelial transplantation advocated for a variety of ocular surface disorders with presumed stem-cell deficiency. Limbal transplantation was performed in 18 patients with ocular surface disease, which included aniridia keratopathy, chronic contact lens-associated epitheliopathy, chemical injury, Stevens-Johnson syndrome, and corneal intraepithelial dysplasia.
METHODS: Limbal allograft transplantation was performed in nine eyes with the use of heterologous limbal tissue from cadaveric donor eyes or live relatives, whereas nine eyes underwent conventional limbal autograft transplantation.
RESULTS: Limbal allograft transplantation resulted in restoration of a stable ocular surface in seven of nine cases, with early visual rehabilitation and significant reduction in symptoms. At a mean follow-up period of 14.7 months, one patient was noted to have failure of the inferior graft related to postoperative microbial keratitis, whereas one patient had acute rejection episode after early cessation of oral cyclosporine. The mean follow-up period for limbal autografts was 27.1 months. Limbal autograft failure occurred in two patients with limbal autograft transplantation for chronic contact lens-associated epitheliopathy. One contact lens wearer had epithelial dysplasia in the fellow eye at the previous donor site. Subclinical involvement of the fellow eye is suggested as a reason for graft failure and donor eye complications in these eyes.
CONCLUSIONS: Although it requires a longer follow-up period, limbal allograft transplantation is a viable procedure for bilateral ocular surface disease and for presumed bilateral disease (viz bilateral exposure to injurious agents) and may be a preferred alternative to limbal autograft transplantation for such patients. The role of immunosuppression is being evaluated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8628556     DOI: 10.1016/s0161-6420(96)30737-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  44 in total

1.  Amniotic membrane transplantation for partial limbal stem cell deficiency.

Authors:  D F Anderson; P Ellies; R T Pires; S C Tseng
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

Review 2.  Amniotic membrane transplantation.

Authors:  H S Dua; A Azuara-Blanco
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

3.  Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects.

Authors:  R B Vajpayee; N Mukerji; R Tandon; N Sharma; R M Pandey; N R Biswas; N Malhotra; S A Melki
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

4.  [Corneal wound healing. II. Treatment of disorders of wound healing].

Authors:  P W Rieck; U Pleyer
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

5.  [Long-term results of autologous transplantation of limbal epithelium cultivated ex vivo for limbal stem cell deficiency].

Authors:  S L Scholz; H Thomasen; K Hestermann; D Dekowski; K-P Steuhl; D Meller
Journal:  Ophthalmologe       Date:  2016-04       Impact factor: 1.059

Review 6.  Outcomes of Limbal Stem Cell Transplant: A Meta-analysis.

Authors:  Qihua Le; Tulika Chauhan; Madeline Yung; Chi-Hong Tseng; Sophie X Deng
Journal:  JAMA Ophthalmol       Date:  2020-06-01       Impact factor: 7.389

7.  Cultured corneal epithelia for ocular surface disease.

Authors:  I R Schwab
Journal:  Trans Am Ophthalmol Soc       Date:  1999

Review 8.  Graft failure: II. Ocular surface complications.

Authors:  Samar A Al-Swailem
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

9.  Long-term outcome and prognostic factor analysis for keratolimbal allografts.

Authors:  Eui Seok Han; Won Ryang Wee; Jin Hak Lee; Mee Kum Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-12       Impact factor: 3.117

10.  Comparison of ex vivo cultivated human limbal epithelial stem cell viability and proliferation on different substrates.

Authors:  Anindita Chakraborty; Jayanta Dutta; Sumantra Das; Himadri Datta
Journal:  Int Ophthalmol       Date:  2013-03-26       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.